Boniva ibandronate regulatory update

FDA said it approved the first generic versions of once-monthly Boniva ibandronate 150 mg tablets to treat and prevent postmenopausal osteoporosis. Apotex Inc. (Toronto, Ontario); Mylan Inc. (NASDAQ...